Brief: Lee's Pharmaceutical Says Unit's Nadroparin Calcium For Injection Obtained Drug Registration Approval
06/08/2020 12:46
Aug 6 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* UNIT'S NADROPARIN CALCIUM FOR INJECTION OBTAINED DRUG
REGISTRATION APPROVAL FROM NMPA
Source text for Eikon: ID:nHKSb7SKJt
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA